Cytek Biosciences, Inc.

NASDAQ:CTKB

4.91 (USD) • At close September 13, 2024
Bedrijfsnaam Cytek Biosciences, Inc.
Symbool CTKB
Munteenheid USD
Prijs 4.91
Beurswaarde 645,694,460
Dividendpercentage 0%
52-weken bereik 3.8 - 9.87
Industrie Medical Devices
Sector Healthcare
CEO Dr. Wenbin Jiang Ph.D.
Website https://cytekbio.com

An error occurred while fetching data.

Over Cytek Biosciences, Inc.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags

Vergelijkbare Aandelen

Exscientia plc logo

Exscientia plc

EXAI

5.03 USD

Prothena Corporation plc logo

Prothena Corporation plc

PRTA

22.11 USD

Veracyte, Inc. logo

Veracyte, Inc.

VCYT

32.92 USD

Clover Health Investments, Corp. logo

Clover Health Investments, Corp.

CLOV

2.99 USD

NextGen Healthcare, Inc. logo

NextGen Healthcare, Inc.

NXGN

23.94 USD

Pacific Biosciences of California, Inc. logo

Pacific Biosciences of California, Inc.

PACB

1.81 USD

Celldex Therapeutics, Inc. logo

Celldex Therapeutics, Inc.

CLDX

44.16 USD

P3 Health Partners Inc. logo

P3 Health Partners Inc.

PIII

0.493 USD

CareDx, Inc logo

CareDx, Inc

CDNA

28.87 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)